Information, Expiry & Status of Health Canada Patents covering Lantus.

France

Insulin Glargine

URL Supplier Web Content

Patent Number

1339044

Strength per Unit

100 IU / ml

Dosage Form

Solution

Human Or VET

Human

Patent Expiration Date

2014-04-01

Date Granted

1997-04-01

Filing Date

1989-09-29

Brand Name

LANTUS

Route of Administration

Subcutaneous

CPhI Worldwide, Milan

Attending

Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Sanofi-Aventis Canada Inc.

France

Insulin Glargine

URL Supplier Web Content

Patent Number

1339044

Strength per Unit

100 IU / ml

Dosage Form

Solution

Human Or VET

Human

Patent Expiration Date

2014-04-01

Date Granted

1997-04-01

Filing Date

1989-09-29

Brand Name

LANTUS

Route of Administration

Subcutaneous

CPhI Worldwide, Milan

Attending

Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Sanofi-Aventis Canada Inc.

France

Insulin Glargine

URL Supplier Web Content

Patent Number

1339044

Strength per Unit

100 U / mL

Dosage Form

Solution (10 mL Vial)

Human Or VET

Human

Patent Expiration Date

2014-04-01

Date Granted

1997-04-01

Filing Date

1989-09-29

Brand Name

LANTUS

Route of Administration

Subcutaneous

CPhI Worldwide, Milan

Attending

Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Sanofi-Aventis Canada Inc.

France

Insulin Glargine

URL Supplier Web Content

Patent Number

2490116

Strength per Unit

100 U / mL

Dosage Form

Solution (10 mL Vial)

Human Or VET

Human

Patent Expiration Date

2023-06-05

Date Granted

2012-07-24

Filing Date

2003-06-05

Brand Name

LANTUS

Route of Administration

Subcutaneous

CPhI Worldwide, Milan

Attending

Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Sanofi-Aventis Canada Inc.

France

Insulin Glargine

URL Supplier Web Content

Patent Number

1339044

Strength per Unit

100 U / ML

Dosage Form

Solution

Human Or VET

Human

Patent Expiration Date

2014-04-01

Date Granted

1997-04-01

Filing Date

1989-09-29

Brand Name

LANTUS

Route of Administration

Subcutaneous

CPhI Worldwide, Milan

Attending

Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Sanofi-Aventis Canada Inc.

France

Insulin Glargine

URL Supplier Web Content

Patent Number

1339044

Strength per Unit

100 U / mL

Dosage Form

solution

Human Or VET

Human

Patent Expiration Date

2014-04-01

Date Granted

1997-04-01

Filing Date

1989-09-29

Brand Name

LANTUS

Route of Administration

Subcutaneous

CPhI Worldwide, Milan

Attending

Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Sanofi-Aventis Canada Inc.

France

Insulin Glargine

URL Supplier Web Content

Patent Number

2792669

Strength per Unit

300 unit / mL - (450 IU)

Dosage Form

SOLUTION

Human Or VET

Human

Patent Expiration Date

2031-05-18

Date Granted

2015-09-29

Filing Date

2011-05-18

Brand Name

TOUJEO SOLOSTAR

Route of Administration

SUBCUTANEOUS

CPhI Worldwide, Milan

Attending